With antibiotic resistance on the rise and chronic infections difficult to treat, researchers are studying what our bodies are already armed with, and LL-37 is proving to be much more intriguing than we ever realized
Animal studies report biological activity after oral administration, especially in gastrointestinal models, which suggests potential local effectiveness
Synergistic Effects: Combined Pathway Modulation When used together, BPC-157 and TB-500 demonstrate complementary actions[6]: Inflammation control : Both peptides reduce excessive inflammatory responses while preserving necessary healing inflammation Vascular support : BPC-157s VEGFR2 activation combined with TB-500s angiogenic effects provide robust blood vessel formation Cellular recruitment : BPC-157s FAK/paxillin signaling paired with TB-500s actin-mediated migration accelerates cell arrival at injury sites Structural remodeling : TB-500s cytoskeletal organization complemented by BPC-157s collagen formation improves tissue integrity Key Mechanistic Insight: The BPC-157 + TB-500 combination addresses tissue repair from multiple angles local cytoprotection and angiogenesis (BPC-157) paired with systemic cellular migration and structural remodeling (TB-500)
Our GHK-Cu peptides meet pharmaceutical-grade standards exceeding 98% purity
Longevity-focused patients may continue indefinitely under ongoing medical supervision
Once reconstituted with bacteriostatic water, GHK-Cu must be stored in the refrigerator between 2 and 8C and used within 60 days
